Ge healthcare announces fda approval of flyrcado (flurpiridaz f 18) injection pet radiotracer for enhanced diagnosis of coronary artery disease

Arlington heights, ill.--(business wire)--ge healthcare announces fda approval of flyrcado (flurpiridaz f 18) injection pet radiotracer for enhanced diagnosis of coronary artery disease.
GEHC Ratings Summary
GEHC Quant Ranking